68 A QIP aimed at improving the diagnostic pathway for lung cancer staged T1b/2N0M0 to limit recurrence, reducing patient morbidity and mortality

IF 5.3 2区医学 Q1 ONCOLOGY

Lung Cancer Pub Date : 2026-02-01 Epub Date: 2026-02-27 DOI:10.1016/j.lungcan.2026.109017

Katija Hunt , Elizabeth Ruth Fuller

引用次数: 0

查看原文本刊更多论文

QIP旨在改善肺癌分期T1b/2N0M0的诊断途径，以限制复发，降低患者的发病率和死亡率

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lung Cancer 医学-呼吸系统

CiteScore

9.40

自引率

3.80%

发文量

407

审稿时长

25 days

期刊介绍： Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.